Under construction – not a live service
Sign in

2024-514788-24-00CompletedPhase 3

Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and of one ointment without active substances for patients with chronic stable plaque poriasis

Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Feb 2025

Next steps

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
306 (actual)
First submitted
30 Jul 2024
Start date
20 Sept 2022
Lead sponsor
Dermapharm AG
Diseases
Psoriasis
EU CT number
2024-514788-24-00
EudraCT number
2020-004081-19

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 306
  • 13 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (13)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Gemeinschaftspraxis Weber & CrainicAugsburgGermanyCompleted
Praxis Dr. Julia ReichleBerlinGermanyCompleted
Fachaerztliche Gemeinschaftspraxis fuer Dermatologie Und Venerologie Allergologie Umweltmedizin Lasermedizin GbRBlankenfelde-MahlowGermanyCompleted
Praxis fuer Dermatologie und VenerologieDresdenGermanyCompleted
Hautzentrum DulmenDülmenGermanyCompleted
Praxis Dr. med. Abdou ZarzourHalleGermanyCompleted
Derma Science GmbHHamburgGermanyCompleted
Hautarztzentrum HammHammGermanyCompleted
Durani Cosmetics GmbHHeidelbergGermanyCompleted
Hautarztpraxis Dr. Offers und Dr. AdaminiIbbenbürenGermanyCompleted
Studienzentrum Dr. med. Beate Schwarz Dermatologie und AllergologieLangenauGermanyCompleted
Haut-und Lasercentrum Potsdam - Dr. med. Tanja FischerPotsdamGermanyCompleted
Hautarztpraxis Dr. Wilfried SteinbornStraubingGermanyCompleted

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.